Optimer Pharmaceuticals (OPTR)

Add to Watchlists Create an Alert
14.49 -0.18  -1.23%   NASDAQ May 24, 5:00PM BATS Real time Currency in USD

Optimer Pharmaceuticals Return on Equity:

-26.98% for Dec. 31, 2012
View Full Chart

Optimer Pharmaceuticals Return on Equity Chart

    Optimer Pharmaceuticals Historical Return on Equity Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 -26.98%
    Sept. 30, 2012 -18.11%
    June 30, 2012 -17.26%
    March 31, 2012 -33.25%
    Dec. 31, 2011 6.18%
    Sept. 30, 2011 -16.11%
    June 30, 2011 -3.02%
    March 31, 2011 14.22%
    Dec. 31, 2010 -91.72%
    Sept. 30, 2010 -89.77%
    June 30, 2010 -87.56%
       
    March 31, 2010 -94.02%
    Dec. 31, 2009 -103.6%
    Sept. 30, 2009 -99.17%
    June 30, 2009 -98.15%
    March 31, 2009 -88.26%
    Dec. 31, 2008 -83.05%
    Sept. 30, 2008 -78.22%
    June 30, 2008 -75.95%
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro

    About Return on Equity (ROE)

    Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

    ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

    Investors generally are interested in company's that have high, increasing returns on equity.
    Learn More

    Get data for

    OPTR Return on Equity Benchmarks

    Companies
    Cubist Pharmaceuticals 13.56%
    AstraZeneca 25.39%
    ViroPharma -9.86%

    OPTR Return on Equity Rankings

    Overall 50th percentile
    3949 of 8009
    Sector 56th percentile
    302 of 687 in Healthcare
    Industry 78th percentile
    53 of 248 in Biotechnology

    OPTR Return on Equity Range, Past 5 Years

    Minimum -103.6% Dec 2009
    Maximum 14.22% Mar 2011
    Average -57.04%